Camouflaging attenuated Salmonella by cryo-shocked macrophages for tumor-targeted therapy

Leyang Wu,Zengzheng Du,Lin Li,Liyuan Qiao,Shuhui Zhang,Xingpeng Yin,Xiaoyao Chang,Chenyang Li,Zichun Hua

DOI: https://doi.org/10.1038/s41392-023-01703-1

IF: 39.3

2024-01-10

Signal Transduction and Targeted Therapy

Abstract:Live bacteria-mediated antitumor therapies mark a pivotal point in cancer immunotherapy. However, the difficulty in reconciling the safety and efficacy of bacterial therapies has limited their application. Improving bacterial tumor-targeted delivery while maintaining biosafety is a critical hurdle for the clinical translation of live microbial therapy for cancer. Here, we developed "dead" yet "functional" Salmonella -loaded macrophages using liquid nitrogen cold shock of an attenuated Salmonella typhimurium VNP20009-contained macrophage cell line. The obtained "dead" macrophages achieve an average loading of approximately 257 live bacteria per 100 cells. The engineered cells maintain an intact cellular structure but lose their original pathogenicity, while intracellular bacteria retain their original biological activity and are delay freed, followed by proliferation. This "Trojan horse"-like bacterial camouflage strategy avoids bacterial immunogenicity-induced neutrophil recruitment and activation in peripheral blood, reduces the clearance of bacteria by neutrophils and enhances bacterial tumor enrichment efficiently after systemic administration. Furthermore, this strategy also strongly activated the tumor microenvironment, including increasing antitumor effector cells (including M1-like macrophages and CD8+ Teffs) and decreasing protumor effector cells (including M2-like macrophages and CD4+ Tregs), and ultimately improved antitumor efficacy in a subcutaneous H22 tumor-bearing mouse model. The cryo-shocked macrophage-mediated bacterial delivery strategy holds promise for expanding the therapeutic applications of living bacteria for cancer.

biochemistry & molecular biology,cell biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to improve the safety and effectiveness of bacterial therapy in cancer treatment. Specifically, the researchers have developed a method of loading attenuated Salmonella by engineering macrophages treated with liquid - nitrogen cold shock, in order to achieve targeted treatment of tumors. This method aims to overcome the problem of difficulty in balancing safety and efficacy in traditional bacterial therapies, especially in reducing adverse reactions caused by bacterial immunogenicity and improving the enrichment efficiency of bacteria at tumor sites. Through this "Trojan horse" - like bacterial camouflage strategy, the researchers hope to enhance the targeted delivery ability of bacteria to tumors while ensuring biosafety, thereby improving the anti - tumor efficacy.